South Korea Draft Device Act To Examine Postmarket Process – Commerce

South Korea's Ministry of Health & Welfare and its Food & Drug Administration (KFDA) will consider the possibility of creating a third-party review process for lower and possibly intermediate-risk devices

More from Archive

More from Medtech Insight